Pharma Mar, S.A. (PHMMF)
OTCMKTS
· Delayed Price · Currency is USD
80.91
0.00 (0.00%)
May 20, 2025, 4:00 PM EDT
Pharma Mar Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 20, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,663 | 1,438 | 816 | 1,238 | 1,175 | 1,606 | Upgrade
|
| Market Cap Growth | 182.01% | 76.17% | -34.05% | 5.37% | -26.88% | 81.25% | Upgrade
|
| Enterprise Value | 1,563 | 1,344 | 672 | 1,084 | 985 | 1,439 | Upgrade
|
| Last Close Price | 80.91 | 81.07 | 46.26 | 69.39 | 62.50 | 87.30 | Upgrade
|
| PE Ratio | 77.42 | 53.17 | 649.51 | 23.46 | 11.12 | 9.57 | Upgrade
|
| PS Ratio | 8.76 | 7.94 | 4.67 | 5.90 | 4.49 | 4.87 | Upgrade
|
| PB Ratio | 7.79 | 6.67 | 3.82 | 5.19 | 5.81 | 12.78 | Upgrade
|
| P/TBV Ratio | 7.83 | 6.70 | 3.84 | 5.22 | 5.84 | 12.91 | Upgrade
|
| P/FCF Ratio | - | - | - | 39.30 | 57.78 | 4.76 | Upgrade
|
| P/OCF Ratio | - | 230.47 | - | 30.22 | 40.22 | 4.71 | Upgrade
|
| EV/Sales Ratio | 7.90 | 7.42 | 3.84 | 5.17 | 3.77 | 4.36 | Upgrade
|
| EV/EBITDA Ratio | 100.26 | 128.91 | - | 22.60 | 9.12 | 7.39 | Upgrade
|
| EV/EBIT Ratio | 180.72 | 200.70 | - | 24.11 | 9.37 | 7.51 | Upgrade
|
| EV/FCF Ratio | -81.28 | - | - | 34.42 | 48.46 | 4.26 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.25 | 0.23 | 0.19 | 0.28 | 0.55 | Upgrade
|
| Debt / EBITDA Ratio | 3.75 | 4.19 | 48.68 | 0.91 | 0.51 | 0.35 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.45 | 2.76 | 0.21 | Upgrade
|
| Asset Turnover | 0.53 | 0.51 | 0.43 | 0.52 | 0.66 | 1.19 | Upgrade
|
| Inventory Turnover | 0.21 | 0.18 | 0.29 | 0.71 | 1.46 | 1.32 | Upgrade
|
| Quick Ratio | 2.23 | 2.29 | 1.98 | 2.18 | 2.93 | 2.31 | Upgrade
|
| Current Ratio | 2.97 | 3.03 | 2.63 | 2.83 | 3.42 | 2.59 | Upgrade
|
| Return on Equity (ROE) | 10.19% | 13.00% | 0.55% | 24.62% | 66.18% | 249.16% | Upgrade
|
| Return on Assets (ROA) | 1.44% | 1.17% | -0.65% | 6.91% | 16.54% | 43.04% | Upgrade
|
| Return on Capital (ROIC) | 1.99% | 1.63% | -0.95% | 10.67% | 29.89% | 77.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 2.40% | - | 14.20% | 32.80% | 66.60% | Upgrade
|
| Earnings Yield | 1.29% | 1.88% | 0.15% | 4.26% | 8.99% | 10.45% | Upgrade
|
| FCF Yield | -1.16% | -0.65% | -3.83% | 2.54% | 1.73% | 21.01% | Upgrade
|
| Dividend Yield | - | 1.02% | 1.55% | 1.00% | 1.18% | 0.84% | Upgrade
|
| Payout Ratio | 57.46% | 43.71% | 1028.06% | 23.83% | 11.71% | 6.42% | Upgrade
|
| Buyback Yield / Dilution | - | 1.98% | 0.81% | 0.12% | 1.31% | 0.77% | Upgrade
|
| Total Shareholder Return | - | 3.00% | 2.37% | 1.12% | 2.49% | 1.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.